These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29568775)

  • 1. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.
    Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
    Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
    Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
    Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
    Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
    Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.
    Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C
    Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
    Zhao F; Shang Y; Zeng C; Gao D; Li K
    Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
    Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
    Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between nucleotide excision repair gene polymorphism and colorectal cancer risk.
    Zhang Y; Wu S; Zhou X; Huang F; Chen R; Wang Y; Wu J
    J Clin Lab Anal; 2019 Oct; 33(8):e22956. PubMed ID: 31568607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
    Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
    BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection.
    Wang BG; Lv Z; Xu Q; Liu YF
    Yi Chuan; 2017 Jan; 39(1):22-31. PubMed ID: 28115302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in nucleotide excision repair genes and endometrial cancer risk.
    Doherty JA; Weiss NS; Fish S; Fan W; Loomis MM; Sakoda LC; Rossing MA; Zhao LP; Chen C
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1873-82. PubMed ID: 21750170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt.
    Kassem AB; Salem SE; Abdelrahim ME; Said AS; Salahuddin A; Hussein MM; Bahnassy AA
    Exp Mol Pathol; 2017 Feb; 102(1):78-85. PubMed ID: 28088319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
    Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.
    Huang MY; Tsai HL; Lin CH; Huang CW; Ma CJ; Huang CM; Chai CY; Wang JY
    J Surg Oncol; 2013 Dec; 108(7):457-64. PubMed ID: 23996617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.